These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9519170)

  • 21. AIDS pacient's long-term battle with multiply recurrent tuberculosis: reinfection or reactivation?
    Reniero A; Beltrán M; de Kantor IN; Ritacco V
    Rev Argent Microbiol; 2010; 42(4):271-3. PubMed ID: 21229196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis in drug users.
    Perlman DC; Salomon N; Perkins MP; Yancovitz S; Paone D; Des Jarlais DC
    Clin Infect Dis; 1995 Nov; 21(5):1253-64. PubMed ID: 8589151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multidrug-resistant tuberculosis. 5. Human immunodeficiency virus infection and multidrug-resistant tuberculosis].
    Fujita A
    Kekkaku; 1998 Nov; 73(11):679-85. PubMed ID: 9866931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On consumption.
    Welty TK; Volmer L
    S D J Med; 1994 Sep; 47(9):326. PubMed ID: 7973600
    [No Abstract]   [Full Text] [Related]  

  • 26. Implications of the growing HIV-1 epidemic for tuberculosis control in Russia.
    Kazionny B; Wells CD; Kluge H; Gusseynova N; Molotilov V
    Lancet; 2001 Nov; 358(9292):1513-4. PubMed ID: 11705567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HIV-tuberculosis time bomb: how can hospitals in developing countries cope?
    Walley J
    World Hosp Health Serv; 1994; 30(1):16-9. PubMed ID: 10135090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis: a spectre has returned.
    J R Soc Health; 1997 Apr; 117(2):73. PubMed ID: 9223844
    [No Abstract]   [Full Text] [Related]  

  • 29. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.
    Reid A; Scano F; Getahun H; Williams B; Dye C; Nunn P; De Cock KM; Hankins C; Miller B; Castro KG; Raviglione MC
    Lancet Infect Dis; 2006 Aug; 6(8):483-95. PubMed ID: 16870527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of tuberculosis associated with HIV infection in Taiwan.
    Hsieh SM; Hung CC; Chen MY; Chang SC; Hsueh PR; Luh KT; Chuang CY
    J Formos Med Assoc; 1996 Dec; 95(12):923-8. PubMed ID: 9000809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Airborne pathogens: infection control and tuberculosis--the Singapore scene.
    Ling ML; Wee M
    Asepsis; 1997; 19(1):17-21. PubMed ID: 9304884
    [No Abstract]   [Full Text] [Related]  

  • 32. Tuberculosis: infection control in hospital and at home.
    Jarvis M
    Nurs Stand; 2010 Sep 15-21; 25(2):41-7. PubMed ID: 20949823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tuberculosis in the AIDS era].
    Mlika-Cabanne N; Larouzé B
    Rev Epidemiol Sante Publique; 1993; 41(6):433-5. PubMed ID: 8296028
    [No Abstract]   [Full Text] [Related]  

  • 34. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.
    Gandhi NR; Nunn P; Dheda K; Schaaf HS; Zignol M; van Soolingen D; Jensen P; Bayona J
    Lancet; 2010 May; 375(9728):1830-43. PubMed ID: 20488523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Report from the 15th Retrovirus Conference. Opportunistic infections: TB, HIV and XDR TB.
    Friedland GH
    AIDS Clin Care; 2008 Apr; 20(4):29. PubMed ID: 19271263
    [No Abstract]   [Full Text] [Related]  

  • 37. Multi drug resistant tuberculosis: what will happen in developing countries?
    Colebunders R; Dujardin B; Taelman H; Portaels F
    Ann Soc Belg Med Trop; 1994 Dec; 74(4):263-7. PubMed ID: 7726660
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis.
    Bandera A; Gori A; Catozzi L; Degli Esposti A; Marchetti G; Molteni C; Ferrario G; Codecasa L; Penati V; Matteelli A; Franzetti F
    J Clin Microbiol; 2001 Jun; 39(6):2213-8. PubMed ID: 11376059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of infection control measures in controlling a nosocomial outbreak of multidrug-resistant tuberculosis among HIV patients in Italy.
    Moro ML; Errante I; Infuso A; Sodano L; Gori A; Orcese CA; Salamina G; D'Amico C; Besozzi G; Caggese L
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):61-8. PubMed ID: 10654646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tuberculosis and HIV infection: experience of the national tuberculosis prevention program in Djibouti: 1990-1996].
    Renoux E; Matan AB; Sevre JP; Mohamed Ali I; Chami D; Vincent V
    Med Trop (Mars); 2002; 62(2):171-6. PubMed ID: 12192716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.